ERBB2 and cancer: Here, we report data that demonstrate that by destabilizing the stable 3’UTR elements of ERBB2 across multiple recalcitrant drug-resistant cancer models, we controlled pervasive ERBB2 oncogenic transcript and specifically degraded the ERBB2 protein and its associated kinases and interactome which triggered apoptosis and killed the tumors and is validated in vivo.